Richard Burr: “I think I can speak for the Chairman in saying that the Committee is committed to do a much better job at understanding…”

I went through a litany in my opening statements of the deficiencies in what FDA committed to and what they missed.

I hope to receive that response soon.

I will work with you as aggressively as I can to get the answers to the questions that are unanswered today on infant formula.

The faster, more predictable, and more accountable the programs are, the more patients stand to benefit from lifesaving, innovative drugs and devices.